Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioequivalence of a test
clarithromycin extended release formulation to an equivalent oral dose of the commercially
available extended release clarithromycin in a test population of 22 adult subjects under fed
conditions.